Header Logo

Connection

RACHEL SCHIFF to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications RACHEL SCHIFF has written about Radiopharmaceuticals.
RACHEL SCHIFF
Connection Strength
0.069
Radiopharmaceuticals
  1. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med. 2007 Sep; 48(9):1501-10.
    View in: PubMed
    Score: 0.069
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.